Morphine inhibits NF-κB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism

Anesthesiology

Volumn 92, Issue 6, 2000, Pages 1677-1684

  Welters, Ingeborg D ^a,b   Menzebach, Axel ^a   Goumon, Yannick ^b   Cadet, Patrick ^b   Menges, Thilo ^a   Hughes, Thomas K ^c   Hempelmann, Gunter ^a   Stefano, George B ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Leukocytes; Opiates; Transcription factors

Indexed keywords

ACETYLCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MORPHINE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0034086908     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200006000-00027     Document Type: Article

References (42)

1. Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, Stefano GB: Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 1996; 156:4845-50
2. Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, Goligorsky MS: Presence of the mu3 opiate receptor in endothelial cells: Coupling to nitric oxide production and vasodilation. J Biol Chem 1995; 270:30290-3
3. Bilfinger TV, Kushnerik V, Bundz S, Liu Y, Stefano GB: Evidence for morphine downregulating immunocytes during cardiopulmonary bypass in a porcine model. Int J Cardiol 1996; 53(suppl):S39-46
4. Kupatt C, Weber C, Wolf DA, Becker BF, Smith TW, Kelly RA: Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium: Role of NFκB. J Mol Cell Cardiol 1997; 29:2599-609
5. Spiecker M, Peng HB, Liao JK: Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IκBα. J Biol Chem 1997; 272: 30969-74
6. Park SK, Lin HL, Murphy S: Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-κB binding to DNA. Biochem J 1997; 322:609-13
7. Peng HB, Spiecker M, Liao JK: Inducible nitric oxide: An autoregulatory feedback inhibitor of vascular inflammation. J Immunol 1998; 161:1970-6
8. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK: Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96:60-8
9. Shin WS, Hong YH, Peng HB, De Caterina R, Libby P, Liao JK: Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma: The role of constitutive NF-κB activity. J Biol Chem 1996; 271:11317-24
10. Sekkai D, Aillet F, Israel N, Lepoivre M: Inhibition of NF-κB and HIV-1 long terminal repeat transcriptional activation by inducible nitric oxide synthase 2 activity. J Biol Chem 1998; 273:3895-900
11. Blackwell TS, Christman JW: The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17:3-9
12. Peng HB, Libby P, Liao JK: Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995; 270:14214-9
13. Matthews JR, Botting CH, Panico M, Morris HR, Hay RT: Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res 1996; 24:2236-42
14. Marcoli M, Ricevuti G, Mazzone A, Bekkering M, Lecchini S, Frigo GM: Opioid-induced modification of granulocyte function. Int J Immunopharmacol 1988; 10:425-33
15. Cuthbertson BH, Galley HF, Webster NR: Effect of exogenous nitric oxide and superoxide on interleukin-8 from human polymorphonuclear leucocytes. Br J Anaesth 1997; 78:714-7
16. Stefano GB, Scharrer B, Smith EM, Hughes TK, Jr, Magazine HT, Bilfinger TV, Hartman AR, Fricchione GL, Liu Y, Makman MH: Opioid and opiate immunoregulatory processes. Crit Rev Immunol 1996; 16: 109-44
17. Foulds S: Novel flow cytometric method for quantifying nuclear binding of the transcription factor nuclear factor kappa B in unseparated human monocytes and polymorphonuclear cells. Cytometry 1997; 29:182-6
18. Fimiani C, Mattocks D, Cavani F, Salzet M, Deutsch DG, Pryor S, Bilfinger TV, Stefano GB: Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: Coupling to nitric oxide release. Cell Signal 1999; 11:189-93
19. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW: In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996; 157:1630-7
20. Makman MH, Bilfinger TV, Stefano GB: Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J Immunol 1995; 154: 1323-30
21. Stefano GB, Digenis A, Spector S, Leung MK, Bilfinger TV, Makman MH, Scharrer B, Abumrad NN: Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc Natl Acad Sci USA 1993; 90:11099-103
22. Ledebur HC, Parks TP: Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells: Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem 1995; 270:933-43
23. Drouet C, Shakhov AN, Jongeneel CV: Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. J Immunol 1991; 147:1694-700
24. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K: Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 1994; 56:554-8
25. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12:141-79
26. Read MA, Whitley MZ, Williams AJ, Collins T: NF-kappa B and I kappa B alpha: An inducible regulatory system in endothelial activation. J Exp Med 1994; 179:503-12
27. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10:405-55
28. Blackwell TS, Blackwell TR, Christman JW: Impaired activation of nuclear factor-kappaB in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation. J Immunol 1997; 158:5934-40
29. Blackwell TS, Blackwell TR, Christman JW: Induction of endotoxin tolerance depletes nuclear factor-kappaB and suppresses its activation in rat alveolar macrophages. J Leukoc Biol 1997; 62:885-91
30. Chen F, Sun SC, Kuh DC, Gaydos LJ, Demers LM: Essential role of NF-kappa B activation in silica-induced inflammatory mediator production in macrophages. Biochem Biophys Res Commun 1995; 214: 985-92
31. Lander HM, Sehajpal PK, Novogrodsky A: Nitric oxide signaling: A possible role for G proteins. J Immunol 1993; 151:7182-7
32. Colasanti M, Persichini T, Menegazzi M, Mariotto S, Giordano E, Caldarera CM, Sogos V, Lauro GM, Suzuki H: Induction of nitric oxide synthase mRNA expression: Suppression by exogenous nitric oxide. J Biol Chem 1995; 270:26731-3
33. Xie QW, Kashiwabara Y, Nathan C: Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269:4705-8
34. Nunokawa Y, Oikawa S, Tanaka S: Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-κB dependent mechanism. Biochem Biophys Res Commun 1996; 223:347-52
35. Stefano GB, Salzet M, Magazine HI, Bilfinger TV: Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J Cardiovasc Pharmacol 1998; 31:813-20
36. Lander HM, Sehajpal P, Levine DM, Novogrodsky A: Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 1993; 150:1509-16
37. Roy S, Cain KJ, Chapin RB, Charboneau RG, Barke RA: Morphine modulates NFκB activation in macrophages. Biochem Biophys Res Commun 1998; 245:392-6
38. Conti L, Hiscott J, Papacchini M, Roulston A, Wainberg MA, Belardelli F, Gessani S: Induction of relA(p65) and I kappa B alpha subunit expression during differentiation of human peripheral blood monocytes to macrophages. Cell Growth Differentiation 1997; 8:435-42
39. Wolff T, Samuelsson H, Hedner T: Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration. Pain 1995; 62:147-54
40. McDonald PP, Bald A, Cassatella MA: Activation of the NF-κB pathway by inflammatory stimuli in human neutrophils. Blood 1997; 89:3421-33
41. Ollivier V, Parry GN, Cobb RR, de Prost D, Mackman N: Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 1996; 271:20828-35
42. de Wit H, Hoogstraten D, Halie RM, Vellenga E: Interferon-gamma modulates the lipopolysaccharide-induced expression of AP-1 and NF-kappa B at the mRNA and protein level in human monocytes. Exp Hematol 1996; 24:228-35